4-氯-2,5,6-三甲基噻吩并[2,3-D]嘧啶 | 83548-58-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并嘧啶酮衍生物
• 中文名称: 4-氯-2,5,6-三甲基噻吩并[2,3-D]嘧啶
• 英文名称: 4-Chlor-2,5,6-trimethylthieno<2,3-d>pyrimidin
• 英文别名: 4-chloro-2,5,6-trimethyl-thieno[2,3-d]pyrimidine；4-chloro-2,5,6-trimethylthieno[2,3-d]pyrimidine；4-Chlor-2,5,6-trimethylthieno[2,3-d]pyrimidin
• CAS: 83548-58-7
• 化学式: C₉H₉ClN₂S
• mdl: MFCD03030423
• 分子量: 212.703
• InChiKey: HDOQGBZKVBVNLU-UHFFFAOYSA-N

物化性质

• 熔点：
  116-117 °C(Solv: ligroine (8032-32-4))
• 沸点：
  257.7±22.0 °C(Predicted)
• 密度：
  1.327±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  54
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S22,S26,S36/37/39
• 危险类别码：
  R36/37/38

SDS

Name:	4-Chloro-2 5 6-trimethylthieno[2 3-d]pyrimidine Material Safety Data Sheet
Synonym:	None Known
CAS:	83548-58-7

Section 1 - Chemical Product MSDS Name:4-Chloro-2 5 6-trimethylthieno[2 3-d]pyrimidine Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
83548-58-7	4-Chloro-2,5,6-trimethylthieno[2,3-d]p	97+	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 83548-58-7: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: yellow
Odor: slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 115.4-116.4 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H9ClN2S
Molecular Weight: 212.70

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Oxidizing agents, bases, amines.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 83548-58-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Chloro-2,5,6-trimethylthieno[2,3-d]pyrimidine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 83548-58-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 83548-58-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 83548-58-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氯-2,5,6-三甲基噻吩并[2,3-D]嘧啶 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以80%的产率得到4-肼基-2,5,6-三甲基噻吩并[2,3-d]嘧啶
  参考文献：
  名称：

  一些新的三唑并噻吩并嘧啶的合成和腺苷受体结合研究。

  摘要：

  新系列的5-烷基/芳基-8,9-二甲基/ 8,9,10,11-四氢[1]苯并噻吩并[3,2-e] [1,2,4]三唑o [4,3- c]嘧啶-3（2H）-硫酮（4a-k）是通过4-肼基-2-烷基/芳基-5,6-二甲基/ 5,6,7,8-四氢[ 1] benzothieno [2,3-d] pyri Midines（3a-k）在碱性条件下使用二硫化碳。通过取代氯，制备4-肼基-2-烷基/芳基-5,6-二甲基/ 5,6,7,8-四氢[1]苯并噻吩并[2,3-d]吡啶亚氨酸（3a-k）用水合肼制得4-氯-2-取代的5,6-二甲基/ 5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶二烯（2a-k）已知的一锅合成。这些化合物对腺苷A（1）/ A（2A）受体的亲和力是在1 microM浓度下测定的。选择表现出超过20％抑制作用的测试化合物，并在六个不同浓度水平下进一步筛选以估计其EC（50）/

  DOI：

  10.1016/j.ejmech.2007.05.001
• 作为产物：
  描述：

  2,5,6-trimethyl-3H-thieno[2,3-d]pyrimidin-4-one 在 三氯氧磷 作用下， 以 1,4-二氧六环 为溶剂， 反应 3.0h， 生成 4-氯-2,5,6-三甲基噻吩并[2,3-D]嘧啶
  参考文献：
  名称：

  Prasad, Mailavaram Raghu; Rao, Akkinepalli Raghu Ram; Rao, Pamulaparthi Shanthan, Synthesis, 2001, # 14, p. 2119 - 2123

  摘要：

  DOI：

文献信息

• [EN] THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS<br/>[FR] THIÉNO[2,3-D]PYRIMIDINES ET BENZOFURO(3,2-D) PYRIMIDINES UTILES EN TANT QU'AGENTS ANTIMICROBIENS
  申请人：UNIV SAINT LOUIS

  公开号：WO2019018359A1

  公开（公告）日：2019-01-24

  The present disclosure provides compounds, methods, and compositions which may be used to treat tuberculosis. In some embodiments, these compounds and compositions have a bactericidal property against Mycobacterium tuberculosis (Mtb). Methods of employing such agents are also provided.

  本公开提供了可用于治疗结核病的化合物、方法和组合物。在某些实施例中，这些化合物和组合物具有对结核分枝杆菌（Mtb）具有杀菌作用的特性。还提供了使用这些药剂的方法。
• Synthesis of 3-Azabicyclo[3.2.0]heptane-Derived Building Blocks via [3+2] Cycloaddition
  作者：Anton A. Homon、Oleksandr V. Hryshchuk、Serhii Trofymchuk、Oleg Michurin、Yuliya Kuchkovska、Dmytro S. Radchenko、Oleksandr O. Grygorenko

  DOI：10.1002/ejoc.201800972

  日期：2018.11.1

  Synthesis of 3‐azabicyclo[3.2.0]heptane‐derived building blocks via [3+2]cycloaddition of cyclobutene‐1‐carboxylate and azomethine ylide is described. It is shown that the title bicyclic scaffold is a three‐dimensional template which is well‐compatible with lead‐oriented parallel synthesis.

  描述了通过环丁烯-1-羧酸酯和甲亚胺叶立德的[3 + 2]环加成反应合成3-氮杂双环[3.2.0]庚烷的结构单元。结果表明标题双环支架是一个三维模板，与基于铅的平行合成很好地兼容。
• [EN] MONOCYCLIC, THIENO, PYRIDO, AND PYRROLO PYRIMIDINE COMPOUNDS AND METHODS OF USE AND MANUFACTURE OF THE SAME<br/>[FR] COMPOSÉS DE PYRIMIDINES MONOCYCLIQUES, THIÉNOPYRIMIDINES, PYRIDOPYRIMIDINES, ET PYRROLOPYRIMIDINES, LEURS PROCÉDÉS D'UTILISATION ET DE FABRICATION
  申请人：UNIV HOLY GHOST DUQUESNE

  公开号：WO2017031176A1

  公开（公告）日：2017-02-23

  The present invention provides monocyclic, thieno, pyrido and pyrrolo pyrimidine compounds. Pharmaceutical compositions comprising one or more of these compounds and optionally comprising a pharmaceutically acceptable salt or hydrate of one or more of the compounds are provided. Preferably, these pharmaceutical compositions further comprise at least one pharmaceutically acceptable carrier. Methods of treating a patient having cancer are provided wherein a therapeutically effective amount of one or more of these compounds or pharmaceutical compositions are administered to the patient.

  本发明提供了单环、噻吩、吡啶和吡咯基嘧啶化合物。提供了包含这些化合物中的一个或多个的药物组合物，可选地包含一个或多个化合物的药用可接受盐或水合物。优选地，这些药物组合物进一步包含至少一种药用可接受的载体。提供了治疗患有癌症的患者的方法，其中向患者施用了这些化合物或药物组合物中的一个或多个的治疗有效量。
• N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
  申请人：Cai Xiong Sui

  公开号：US20070099877A1

  公开（公告）日：2007-05-03

  Disclosed are N-aryl-thienopyrimidin-4-amines and analogs thereof, represented by the Formulae I-II: wherein Ar and R 1 -R 4 are defined herein. The present invention relates to the discovery that compounds having Formulae I-II are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  揭示了N-芳基噻吩吡嘧啶-4-胺及其类似物，由以下的式子I-II表示：其中Ar和R1-R4在此有所定义。本发明涉及发现具有式子I-II的化合物是半胱氨酸蛋白酶的激活剂和凋亡诱导剂。因此，本发明的半胱氨酸蛋白酶激活剂和凋亡诱导剂可用于诱导在各种临床病况中发生细胞死亡，这些病况中存在细胞不受控制的生长和异常细胞的扩散。
• N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
  申请人：Cai Xiong Sui

  公开号：US20070213305A1

  公开（公告）日：2007-09-13

  Disclosed are N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs thereof, represented by the Formulae I-II: wherein Ar, R 1 -R 4 and R 10 are defined herein. The present invention relates to the discovery that compounds having Formulae I-II are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明涉及公开的N-烷基-N-芳基噻唑嘧啶-4-胺及其类似物，其由式I-II表示：其中Ar、R1-R4和R10如本文所定义。本发明关于发现具有式I-II的化合物是caspase的激活剂和凋亡诱导剂。因此，本发明的caspase激活剂和凋亡诱导剂可用于在多种临床情况下诱导细胞死亡，其中发生异常细胞的不受控制的生长和扩散。